Access the full text.
Sign up today, get DeepDyve free for 14 days.
D. Cella, Chanita Hughes, A. Peterman, Chih-Hung Chang, B. Peshkin, M. Schwartz, L. Wenzel, A. Lemke, A. Marcus, C. Lerman (2002)A brief assessment of concerns associated with genetic testing for cancer: the Multidimensional Impact of Cancer Risk Assessment (MICRA) questionnaire.
Health psychology : official journal of the Division of Health Psychology, American Psychological Association, 21 6
S. Ertmański, K. Metcalfe, J. Trempała, M. Głowacka, J. Lubiński, S. Narod, J. Gronwald (2009)Identification of patients at high risk of psychological distress after BRCA1 genetic testing.
Genetic testing and molecular biomarkers, 13 3
L. d'Agincourt-Canning (2001)Experiences of genetic risk: disclosure and the gendering of responsibility.
Bioethics, 15 3
B. Meiser, J. Halliday (2002)What is the impact of genetic counselling in women at increased risk of developing hereditary breast cancer? A meta-analytic review.
Social science & medicine, 54 10
D. Thompson, D. Easton (2001)Variation in cancer risks, by mutation position, in BRCA2 mutation carriers.
American journal of human genetics, 68 2
Sining Chen, G. Parmigiani (2007)Meta-analysis of BRCA1 and BRCA2 penetrance.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 25 11
Kathryn Schlich-Bakker, H. Kroode, M. Ausems (2006)A literature review of the psychological impact of genetic testing on breast cancer patients.
Patient education and counseling, 62 1
I. Oostrom, H. Meijers-Heijboer, L. Lodder, H. Duivenvoorden, A. Gool, C. Seynaeve, C. Meer, J. Klijn, B. Geel, C. Burger, J. Wladimiroff, A. Tibben (2003)Long-term psychological impact of carrying a BRCA1/2 mutation and prophylactic surgery: a 5-year follow-up study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 21 20
Esmé Finlay, J. Stopfer, Eric Burlingame, Katherine Evans, K. Nathanson, B. Weber, K. Armstrong, T. Rebbeck, S. Domchek (2008)Factors determining dissemination of results and uptake of genetic testing in families with known BRCA1/2 mutations.
Genetic testing, 12 1
Nina Hallowell, A. Ardern-jones, Ros Eeles, C. Foster, Anneke Lucassen, Clare Moynihan, Maggie Watson (2005)Men’s Decision-Making About Predictive BRCA1/2 Testing: The Role of Family
Journal of Genetic Counseling, 14
A. Wit, A. Tibben, P. Frets, E. Meijers-Heijboer, P. Devilee, M. Niermeijer (1996)Males at–risk for the BRCA1‐1ene, the psychological impact
L. Denayer, A. Boogaerts, K. Philippe, E. Legius, G. Evers‐Kiebooms (2009)BRCA1/2 predictive testing and gender: uptake, motivation and psychological characteristics.
Genetic counseling, 20 4
M. Schwartz, H. Valdimarsdottir, T. Demarco, B. Peshkin, W. Lawrence, Jessica Rispoli, K. Brown, C. Isaacs, S. O’Neill, R. Shelby, S. Grumet, M. McGovern, Sarah Garnett, H. Bremer, S. Leaman, Kathryn O'Mara, Sarah Kelleher, Kathryn Komaridis (2009)Randomized trial of a decision aid for BRCA1/BRCA2 mutation carriers: impact on measures of decision making and satisfaction.
Health psychology : official journal of the Division of Health Psychology, American Psychological Association, 28 1
A. Antoniou, P. Pharoah, S. Narod, H. Risch, J. Eyfjord, J. Hopper, N. Loman, Hampus Olsson, O. Johannsson, Å. Borg, B. Pasini, P. Radice, S. Manoukian, D. Eccles, N. Tang, E. Oláh, H. Anton-Culver, E. Warner, J. Lubiński, J. Gronwald, B. Górski, H. Tulinius, S. Thorlacius, H. Eerola, H. Nevanlinna, K. Syrjäkoski, O. Kallioniemi, D. Thompson, Chris Evans, J. Peto, F. Lalloo, D. Evans, D. Easton (2003)Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.
American journal of human genetics, 72 5
D. Easton, D. Ford, D. Bishop (1995)Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.
American journal of human genetics, 56 1
K. Graves, B. Peshkin, C. Halbert, T. Demarco, C. Isaacs, M. Schwartz (2006)Predictors and outcomes of contralateral prophylactic mastectomy among breast cancer survivors
Breast Cancer Research and Treatment, 104
J. Zabora, K. Brintzenhofeszoc, B. Curbow, C. Hooker, S. Piantadosi (2001)The prevalence of psychological distress by cancer site
P. Daly, C. Nolan, A. Green, W. Ormiston, N. Cody, T. Mcdevitt, B. O'hici, D. Byrne, E. McDermott, D. Carney, N. O’Higgins, D. Barton (2003)Predictive testing for BRCA1 and 2 mutations: a male contribution.
Annals of oncology : official journal of the European Society for Medical Oncology, 14 4
J. Hamilton, M. Lobel, A. Moyer (2009)Emotional distress following genetic testing for hereditary breast and ovarian cancer: a meta-analytic review.
Health psychology : official journal of the Division of Health Psychology, American Psychological Association, 28 4
H. Lynch, S. Lemon, C. Durham, S. Tinley, Chris Connolly, J. Lynch, Jonathan Surdam, Ernest Orinion, Sue Slominski‐Caster, P. Watson, C. Lerman, P. Tonin, Gilbert Lenoir, O. Serova, S. Narod (1997)A descriptive study of BRCA1 testing and reactions to disclosure of test results
A. Mitra, E. Bancroft, Y. Barbáchano, E. Page, C. Foster, C. Jameson, G. Mitchell, G. Lindeman, Sandra Stapleton, G. Suthers, D. Evans, D. Crüger, I. Blanco, Catherine Mercer, J. Kirk, L. Maehle, S. Hodgson, L. Walker, L. Izatt, F. Douglas, Katherine Tucker, H. Dorkins, V. Clowes, Allison Male, Andrés Donaldson, C. Brewer, R. Doherty, B. Bulman, P. Osther, M. Salinas, D. Eccles, K. Axcrona, I. Jobson, B. Newcombe, C. Cybulski, W. Rubinstein, S. Buys, S. Townshend, E. Friedman, S. Domchek, T. Cajal, A. Spigelman, Soo-Hwang Teo, N. Nicolai, N. Aaronson, A. Ardern-jones, C. Bangma, D. Dearnaley, J. Eyfjord, A. Falconer, Henrik Grönberg, F. Hamdy, O. Johannsson, V. Khoo, Z. Kote-Jarai, H. Lilja, J. Lubiński, J. Melia, C. Moynihan, S. Peock, G. Rennert, F. Schröder, Paul Sibley, M. Suri, Penny Wilson, Y. Bignon, S. Strom, M. Tischkowitz, A. Liljegren, D. Ilencikova, A. Ābele, K. Kyriacou, C. Asperenvan, L. Kiemeney, D. Easton, R. Eeles (2011)Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT study
BJU International, 107
A. Liede, B. Karlan, S. Narod (2004)Cancer risks for male carriers of germline mutations in BRCA1 or BRCA2: a review of the literature.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 22 4
KD Graves, MD Schwartz (2008)Hereditary breast cancer: risk, prevention, and management
Bettina Meiser, Phyllis Butow, M. Friedlander, Alexandra Barratt, Vivienne Schnieden, Maggie Watson, Judith Brown, K. Tucker (2002)Psychological impact of genetic testing in women from high-risk breast cancer families.
European journal of cancer, 38 15
K. Tercyak, C. Lerman, B. Peshkin, Chanita Hughes, D. Main, C. Isaacs, M. Schwartz (2001)Effects of coping style and BRCA1 and BRCA2 test results on anxiety among women participating in genetic counseling and testing for breast and ovarian cancer risk.
Health psychology : official journal of the Division of Health Psychology, American Psychological Association, 20 3
G. Goelen, A. Rigo, M. Bonduelle, J. Grève (1999)Moral concerns of different types of patients in clinical BRCA1/2 gene mutation testing.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 17 5
M. Daly (2009)The Impact of Social Roles on the Experience of Men in BRCA1/2 Families: Implications for Counseling
Journal of Genetic Counseling, 18
D Thompson, DF Easton (2002)Cancer incidence in BRCA1 mutation carriers
J Natl Cancer Inst, 94
Deborah Thompson, D. Easton (2002)Cancer Incidence in BRCA1 mutation carriers.
Journal of the National Cancer Institute, 94 18
(1999)Cancer risks in BRCA2 mutation carriers
J Natl Cancer Inst, 91
M. Horowitz, N. Wilner, W. Alvarez (1979)Impact of Event Scale: A Measure of Subjective Stress
Psychosomatic Medicine, 41
Ashley Smith, A. Dougall, D. Posluszny, T. Somers, W. Rubinstein, A. Baum (2008)Psychological distress and quality of life associated with genetic testing for breast cancer risk
K. Graves, L. Wenzel, M. Schwartz, G. Luta, P. Wileyto, S. Narod, B. Peshkin, A. Marcus, D. Cella, Susan Emsbo, D. Barnes, C. Halbert (2010)Randomized Controlled Trial of a Psychosocial Telephone Counseling Intervention in BRCA1 and BRCA2 Mutation Carriers
Cancer Epidemiology, Biomarkers & Prevention, 19
D. Ford, D. Easton, Michael Stratton, S. Narod, D. Goldgar, P. Devilee, D. Bishop, B. Weber, G. Lenoir, J. Chang-Claude, H. Sobol, M. Teare, J. Struewing, A. Arason, S. Scherneck, J. Peto, T. Rebbeck, P. Tonin, S. Neuhausen, R. Barkardottir, J. Eyfjord, H. Lynch, B. Ponder, S. Gayther, J. Birch, A. Lindblom, D. Stoppa-Lyonnet, Y. Bignon, Å. Borg, U. Hamann, N. Haites, Rodney Scott, C. Maugard, H. Vasen, S. Seitz, L. Cannon-Albright, A. Schofield, M. Zelada-Hedman (1998)Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium.
American journal of human genetics, 62 3
C. Foster, M. Watson, R. Eeles, D. Eccles, S. Ashley, R. Davidson, J. Mackay, P. Morrison, Penny Hopwood, D. Evans (2007)Predictive genetic testing for BRCA1/2 in a UK clinical cohort: three-year follow-up
British Journal of Cancer, 96
A. Juan, C. Wakefield, N. Kasparian, J. Kirk, J. Tyler, Kathy Tucker (2008)Development and pilot testing of a decision aid for men considering genetic testing for breast and/or ovarian cancer-related mutations (BRCA1/2).
Genetic testing, 12 4
M. Watson, C. Foster, R. Eeles, D. Eccles, S. Ashley, R. Davidson, J. Mackay, P. Morrison, Penny Hopwood, D. Evans (2004)Psychosocial impact of breast/ovarian (BRCA1/2) cancer-predictive genetic testing in a UK multi-centre clinical cohort
British Journal of Cancer, 91
M. Schwartz, B. Peshkin, Chanita Hughes, D. Main, C. Isaacs, C. Lerman (2002)Impact of BRCA1/BRCA2 mutation testing on psychologic distress in a clinic-based sample.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 20 2
A. Liede, K. Metcalfe, D. Hanna, E. Hoodfar, C. Snyder, C. Durham, H. Lynch, S. Narod (2000)Evaluation of the needs of male carriers of mutations in BRCA1 or BRCA2 who have undergone genetic counseling.
American journal of human genetics, 67 6
A. Benson, T. Abrams, E. Ben-Josef, P. Bloomston, J. Botha, B. Clary, A. Covey, S. Curley, M. D'Angelica, Rene Davila, W. Ensminger, J. Gibbs, D. Laheru, M. Malafa, J. Marrero, S. Meranze, S. Mulvihill, James Park, J. Posey, J. Sachdev, R. Salem, E. Sigurdson, C. Sofocleous, J. Vauthey, A. Venook, L. Goff, Y. Yen, A. Zhu (2009)NCCN clinical practice guidelines in oncology: hepatobiliary cancers.
Journal of the National Comprehensive Cancer Network : JNCCN, 7 4
Ken Smith, Jennifer West, R. Croyle, Jeffrey Botkin (1999)Familial context of genetic testing for cancer susceptibility: moderating effect of siblings' test results on psychological distress one to two weeks after BRCA1 mutation testing.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 8 4 Pt 2
T. Wagner, R. Möslinger, G. Langbauer, R. Ahner, E. Fleischmann, A. Auterith, A. Friedmann, T. Helbich, C. Zielinski, E. Pittermann, M. Seifert, P. Oefner, the Group (2000)Attitude towards prophylactic surgery and effects of genetic counselling in families with BRCAmutations
British Journal of Cancer, 82
L. Derogatis, N. Melisaratos (1983)The Brief Symptom Inventory: an introductory report
Psychological Medicine, 13
H. Olsson (1999)Cancer risks in BRCA2 mutation carriers.
Journal of the National Cancer Institute, 91 15
L. Lodder, P. Frets, R. Trijsburg, A. Tibben, E. Meijers-Heijboer, H. Duivenvoorden, A. Wagner, Conny Meer, P. Devilee, C. Cornelisse, M. Niermeijer (2001)Men at risk of being a mutation carrier for hereditary breast/ovarian cancer: an exploration of attitudes and psychological functioning during genetic testing
European Journal of Human Genetics, 9
TM Wagner, R Moslinger, G Langbauer (2000)Attitude towards prophylactic surgery and effects of genetic counselling in families with BRCA mutations. Austrian Hereditary Breast and Ovarian Cancer Group
Br J Cancer, 82
Few studies have quantitatively evaluated the uptake and outcomes of BRCA1/2 genetic counseling and testing in men. We conducted a prospective longitudinal study to describe and compare uptake of and psychosocial outcomes following BRCA1/2 testing in a sample of men and women at high-risk for carrying a BRCA1/2 mutation. Men (n = 98) and women (n = 243) unaffected with cancer completed baseline assessments prior to genetic counseling and testing and then 6- and 12-months post-testing. Most men (n = 94; 95.9%) opted to have genetic testing, of whom 44 received positive BRCA1/2 genetic test results and 50 received true negative results. Among women, 93.4% had genetic testing, of whom 79 received positive results and 148 received negative results. In multivariate models, male BRCA1/2 carriers reported significantly higher genetic testing distress (6-months: Z = 4.48, P < 0.0001; 12-months: Z = 2.78, P < 0.01) than male non-carriers. After controlling for baseline levels of distress, no statistically significant differences emerged between male and female BRCA1/2 carriers in psychological distress at 12-months post-testing, although absolute differences were evident over time. Predictors of distress related to genetic testing among male carriers at 12-months included higher baseline cancer-specific distress (Z = 4.73, P < 0.0001) and being unmarried (Z = 2.18, P < 0.05). Similarly, baseline cancer-specific distress was independently associated with cancer-specific distress at 6- (Z = 3.66, P < 0.001) and 12-months (Z = 4.44, P < 0.0001) post-testing among male carriers. Clinically, our results suggest that pre-test assessment of distress and creation of educational materials specifically tailored to the needs and concerns of male carriers may be appropriate in this important but understudied high-risk group.
Familial Cancer – Springer Journals
Published: Mar 2, 2011
Access the full text.
Sign up today, get DeepDyve free for 14 days.